➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Mallinckrodt
Harvard Business School
Colorcon
Boehringer Ingelheim
Johnson and Johnson
Merck

Last Updated: May 16, 2021

DrugPatentWatch Database Preview

Hisun Pharm Hangzhou Company Profile

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

What is the competitive landscape for HISUN PHARM HANGZHOU, and what generic and branded alternatives to HISUN PHARM HANGZHOU drugs are available?

HISUN PHARM HANGZHOU has twenty approved drugs.



Summary for Hisun Pharm Hangzhou
US Patents:0
Tradenames:17
Ingredients:17
NDAs:20

Drugs and US Patents for Hisun Pharm Hangzhou

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Hisun Pharm Hangzhou DONEPEZIL HYDROCHLORIDE donepezil hydrochloride TABLET, ORALLY DISINTEGRATING;ORAL 205269-001 Jul 27, 2018 AB RX No No   Get Started for $10   Get Started for $10
Hisun Pharm Hangzhou LEVETIRACETAM levetiracetam TABLET, EXTENDED RELEASE;ORAL 207175-002 Sep 28, 2017 AB RX No No   Get Started for $10   Get Started for $10
Hisun Pharm Hangzhou OLANZAPINE olanzapine TABLET;ORAL 206924-001 Dec 31, 2020 AB RX No No   Get Started for $10   Get Started for $10
Hisun Pharm Hangzhou OLANZAPINE olanzapine TABLET;ORAL 206924-006 Dec 31, 2020 AB RX No No   Get Started for $10   Get Started for $10
Hisun Pharm Hangzhou PRAVASTATIN SODIUM pravastatin sodium TABLET;ORAL 206061-003 Nov 23, 2018 DISCN No No   Get Started for $10   Get Started for $10
Hisun Pharm Hangzhou DOXORUBICIN HYDROCHLORIDE doxorubicin hydrochloride INJECTABLE;INJECTION 206062-001 May 13, 2019 DISCN No No   Get Started for $10   Get Started for $10
Hisun Pharm Hangzhou DONEPEZIL HYDROCHLORIDE donepezil hydrochloride TABLET;ORAL 202410-001 Mar 24, 2017 DISCN No No   Get Started for $10   Get Started for $10
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

McKesson
Medtronic
Moodys
Express Scripts
Johnson and Johnson
Dow

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.